BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Research Centre for Biomedical Engineering - ECPv6.3.7//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Research Centre for Biomedical Engineering
X-ORIGINAL-URL:https://creb.upc.edu
X-WR-CALDESC:Events for Research Centre for Biomedical Engineering
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20220907T100000
DTEND;TZID=UTC:20220907T120000
DTSTAMP:20260405T072821
CREATED:20220905T142503Z
LAST-MODIFIED:20220905T142611Z
UID:11309-1662544800-1662552000@creb.upc.edu
SUMMARY:CREB Council Meeting
DESCRIPTION:
URL:https://creb.upc.edu/event/creb-council-meeting/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20221020T110000
DTEND;TZID=UTC:20221020T123000
DTSTAMP:20260405T072821
CREATED:20221017T105151Z
LAST-MODIFIED:20221017T105405Z
UID:11560-1666263600-1666269000@creb.upc.edu
SUMMARY:“Key legal aspects of a technology-based start-up” - Xartec Salut Formation
DESCRIPTION:Xartec Salut Formation – “Key legal aspects of a technology-based start-up”\n\n\n\nWe will review the generally acceptable practice in the distribution of the share capital\, as well as the governing bodies of the start-up. The main documents that must be in place in any start-up and the main clauses that need to be present in such documents. \nWe will also discuss the main terms and conditions that we will usually find in an investments agreement and the main aspects to manage and limit the responsibility of the founders. We will also visit the modalities of investments and the main instruments available for such investments. We will review a numeric example to calculate the percentage of the share capital that a pre-money valuation may represent. \nWe will also review the main types of investment plans for key employees\, directors and collaborators as well as their main features. \nWe will analyze the main items involved in the transfer of technology from the institutions to the start-up and the international standards in such technology transfer. We will also review the structure of the license agreements\, and the main terms and conditions of such agreements. We will discuss the main stages in the exploitation of the technology and the legal documents available in each of such stages. \nIn preparation for an eventual sale of an start-up\, we will review a number of liquidation preference clauses that the investors usually require to be present in their investment and shareholders agreements. \nWe will also review the main aspects of the protection of personal data which is regulated by Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 Open in new window\, on the protection of natural persons with regard to the processing of personal data and on the free movement of such data (General Data Protection Regulations) and the provisions of the Organic Law 3/2018\, of 5 December\, on Personal Data Protection and digital rights guarantee. We will analyze the main notions of data controller and registry of processing activities\, the purpose and data categories\, the legitimation or legal basis of the personal data processing\, preservation of data\, the transmission of data\, international transfer of data\, the legal rights of the interested parties\, and the role of the data protection officer (DPO)​​. \n\n\n\nJoin here: https://meet.google.com/jir-wung-nur
URL:https://creb.upc.edu/event/xartec-salut-formation-key-legal-aspects-of-a-technology-based-start-up/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20221103T110000
DTEND;TZID=UTC:20221103T123000
DTSTAMP:20260405T072821
CREATED:20221102T164055Z
LAST-MODIFIED:20221102T164055Z
UID:11622-1667473200-1667478600@creb.upc.edu
SUMMARY:"The adventure of creating a startup from the CSIC" – Xartec Salut Formation
DESCRIPTION:ABOUT THE SESSION \nIn January 2003 we got the approval of the Council of Ministers to create the first “sociedad limitada” in which the CSIC was a partner. The company was called Biopolis and focused on offering R&D services for the Spanish agri-food industry (technically a CRO). \nAfter two years we were already generating profits and after four years we reinvested all the profits generated in founding Lifesequencing SL\, the first Spanish massive genome company. In this adventure we were accompanied by Secugen SL\, another CSIC spin-off. In the following years we expanded our capabilities in genomics\, microbial physiology\, animal models and scale-up and industrial production while increasing our customers in the European Union and LATAM until 2016\, when we reached a staff of 45 professionals with a turnover of almost 4 million euros. It was then when we decided to offer a part of the shareholding for the entry of a new partner to help us grow in North America and APAC. \nThen Archer Daniels Midland Co (ADM) arrived and acquired 90% of the shares. Since then we have been part of this large multinational agri-food company. They bought most of ADM’s shares because we were a company that developed ingredients using high-quality science as the driving force and that is what we continue to do. \nThroughout this conference I will explain this journey and how my personal and professional life has changed over these twenty years. \n  \nABOUT THE SPEAKER \nHe has a degree and a PhD in Biological Sciences from the University of Valencia. He did his PhD working at the Department of Molecular Genetics of the pharmaceutical company Antibioticos S.A. He carried out post-doctoral stays in the Wageningen University of Agriculture (The Netherlands). \nHe was Professor of Food Technology at the University of Valencia and Research Professor at the Institute of Agrochemistry and Food Technology (IATA) of the CSIC. He is currently on leave of absence from both academic responsibilities. In 2003 he founded the biotechnology company Biopolis S.L. specialized in microbial biotechnology and in 2008 the company Lifesequencing S.L. specialized in massive genome sequencing. Both companies were acquired in 2017 by the US multinational company Archer Daniels Midland Co (ADM). \nHe is currently Distinguished Research Fellow Microbiome at ADM and is the scientific director of the microbiome platform of this company. His technological results are protected by thirty patent families covering more than four hundred national and international patents\, most of them transferred and in use. He has published more than 160 articles in prestigious international journals indexed in the Science Citation Index. He has been awarded the Prize of the Spanish Society of Microbiology\, the Prize for Scientific Trajectory of the Danone Institute\, the European Prize for Scientific Dissemination\, the Juan de la Cierva National Research Prize\, the International Hippocrates Prize\, the Medal for Innovation of the García Cabrerizo Foundation and the International Nutrachampion Prize. \nHe is Full Member of the Royal Academy of Engineering of Spain. \nHe belongs to the Governing Council of the Spanish National Research Council. \n  \nJoin here the formative session \n 
URL:https://creb.upc.edu/event/the-adventure-of-creating-a-startup-from-the-csic-xartec-salut-formation/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221104
DTEND;VALUE=DATE:20221107
DTSTAMP:20260405T072821
CREATED:20220905T143303Z
LAST-MODIFIED:20220905T143412Z
UID:11314-1667520000-1667779199@creb.upc.edu
SUMMARY:Innovation Challenge - Xartec Salut
DESCRIPTION:Hacking the future of HealthTech\n“Almost always\, great new ideas don’t come from one person\, but from the intersection of functions or people who have never met before.” — Clayton M. Christensen \nThe biggest Innovation challenge in the HealthTech sector of Catalonia arrives in autumn. “Hacking the Future of Health Technologies” is a 3 days Hackathon where several multidisciplinary groups will ideate a solution to current challenges in the sector. The best ideas will be awarded by sponsors and teams will have the opportunity to win different prizes\, including mentorships to develop the winning project towards a proof of concept phase. It will be an explosion of creativity and innovation aimed to connect the best talent with professional opportunities. \nThis event will take place in the Master Classroom of the UPC\, Campus Nord (C/Jordi Girona\, 1-3\, 08034).
URL:https://creb.upc.edu/event/innovation-challenge-xartec-salut/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221110
DTEND;VALUE=DATE:20221111
DTSTAMP:20260405T072821
CREATED:20220905T143048Z
LAST-MODIFIED:20220905T143548Z
UID:11311-1668038400-1668124799@creb.upc.edu
SUMMARY:Health Tech 2030 - Xartec Salut
DESCRIPTION:HealthTech2030\n\n\n\n\nAn unique summit envisioning to be that necessary showcase to visualize and pre-conceive health technologies in 2030. Activities include inspirational sessions with changemakers\, spaces for discussion and futurescaping\, interactive workshops and networking. A defining element of the Summit is the prospect for all involved to engage in a live discussion and debate around future health technology challenges\, opportunities and resulting new economies led innovation experts\, researchers\, entrepreneurs and facilitators during our sessions program. Invaluable insights from our diversen audience will be published in a professionally curated ground-breaking report\, and disseminated worldwide to influence decision-makers\, encourage our health tech ecosystem and shape the future for the better. \nTake advantage of this special opportunity to connect one-on-one with startup leaders\, researchers\, innovators\, investors and thinkers in an exclusive setting. Health Tech 2020 is an invitation-only event with the best and brightest top-level industry\, academic\, policy players\, entrepreneurs and investors in attendance. It is an event to cross-innovate\, forming new partnerships\, strategies and opening disruptive discussions with a diverse gathering of people who are working or contribute for the new challenges of the future. \n\n\nThis event will take place at the Palo Alto Market\, Barcelona
URL:https://creb.upc.edu/event/health-tech-2030-xartec-salut/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20221117T110000
DTEND;TZID=UTC:20221117T123000
DTSTAMP:20260405T072821
CREATED:20221123T162841Z
LAST-MODIFIED:20221123T162841Z
UID:11728-1668682800-1668688200@creb.upc.edu
SUMMARY:"Financing formulas for HealthTech Start-Ups" – Xartec Salut Formation
DESCRIPTION:Session description \nFinancial formulas for HealthTech start-ups will serve to have a first approach to the range of financing formulas available for start-ups\, their pros/cons\, especially on venture capital\, as well as to understand some of the start-ups\, as well as to understand some of the formulas for business evaluating. This session will be useful to get used to the terms and language used by investors\, to understand their reasoning\, decision drivers in order to align the messages to them. \nThis session will give you an idea of the basic financial structure of a company and how to structure it financially as well as to learn some methods for business valuation. \n  \nSpeaker’s bio \nSergio San Agustín is a Chemical Engineer: He holds a degree in Business Administration\, a Master’s degree in Financial Advisory from IEB\, an MBA from Tilburg University\, and Ignite Fast Track diploma from Cambridge University. \nSergio has 15 years of experience in innovation and early stage venture capital. He has developed his career in big corporations such as Danone and Moehs Group\, as well as venture capital firms such as Caixa Capital Risc where he managed for 5 years several technology transfer and early stage venture capital initiatives such as CaixaImpulse. Sergio has also collaborated for multiple research centers and universities as mentor\, advisor and trainer\, and managed the valorization and tech transfer initiative Xartec Salut at UPC with 17 participating institutions in Catalonia. He is currently the Investment Director at Clave Capital. \n#FEDERrecerca #FonsUECat
URL:https://creb.upc.edu/event/financing-formulas-for-healthtech-start-ups-xartec-salut-formation/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20221124T110000
DTEND;TZID=UTC:20221124T123000
DTSTAMP:20260405T072821
CREATED:20221123T164052Z
LAST-MODIFIED:20221123T165208Z
UID:11731-1669287600-1669293000@creb.upc.edu
SUMMARY:"Communication of the invention: Tech-Transfer project" – Xartec Salut Formation
DESCRIPTION:Session description \nThis session covers the commercial part of the tech-transfer work\, starting with the communication of the invention\, including the preparation of the technology offer\, identification of the correct profile within the companies to communicate the invention and their contact information\, and how to correctly contact them to maximize the chance of getting a response. And\, once we achieve a meeting with a company\, how to properly set this meeting to optimize the chances of transferring our technology. This session packs a lot of resources and practical information in a format aimed to be directly used in most tech-transfer scenarios. \n  \nSpeaker’s bio \nVicente’s background is in Human Biotechnology\, holding an MBA and a Master in Business Creation and Intellectual Property by the University of Gothenburg. Vicente’s experience ranges from pharmaceutical sales\, Intellectual property\, business development\, and tech-transfer. Currently\, he is co-founder and co-director of Viromii\, a consultancy firm focused on supporting valorization and tech-transfer operations of public and private R&D institutions. \n  \n#FEDERrecerca #FonsUECat \n 
URL:https://creb.upc.edu/event/communication-of-the-invention-tech-transfer-project-xartec-salut-formation/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20231108T150000
DTEND;TZID=UTC:20231108T203000
DTSTAMP:20260405T072821
CREATED:20231019T151253Z
LAST-MODIFIED:20231019T151253Z
UID:12222-1699455600-1699475400@creb.upc.edu
SUMMARY:HEALTH TECH 2030 by Xartec Salut
DESCRIPTION:HealthTech2030 is aimed at exploring and exploiting emerging opportunities and challenges of future health technologies through disruptive discussions with a diverse gathering of people who are working or contribute for the new challenges of the future. \nThe event will provide the opportunity to learn about the future challenges of the healthcare system and to work together to resolve them through technology. \nTake advantage of this rare opportunity to connect one-on-one with startup leaders\, researchers\, innovators\, investors and thinkers in an exclusive setting… \n  \n 
URL:https://creb.upc.edu/event/health-tech-2030-by-xartec-salut/
END:VEVENT
END:VCALENDAR